Table 2.
Comorbidities among studied groups
| Patients with definite neurological disease, N = 117, n (%) | Patients with acute CNS disease, n = 75, n (%) | Patients with acute PNS disease, n = 42, n (%) | p value | |
|---|---|---|---|---|
| Comorbidities | 79 (67.5) | 57 (76) | 22 (52.4) | 0.008 |
| Hypertension | 53 (45.3) | 38 (50.7) | 15 (36.7) | 0.119 |
| Ischemic heart | 20 (17.1) | 14 (18.7) | 6 (14.3) | 0.546 |
| Diabetes mellitus | 41 (35) | 25 (33.3) | 16 (38.1) | 0.605 |
| Impaired liver function | 6 (5.1) | 6 (8) | 0 | 0.218 |
| Impaired renal function | 10 (8.4) | 9 (12) | 1 (2.4) | 0.074 |
| Chest disease | 4 (3.4) | 2 (2.7) | 2 (4.8) | 0.550 |
| Neurological disease (types)* | 14 (12.0) | 11 (14.7) | 3 (7.1) | 0.229 |
CNS, central nervous system; PNS, peripheral nervous system; PD, Parkinson's disease; AD, Alzheimer's disease; MG, myasthenia gravis. * Ischemic stroke, hemorrhagic stroke, epilepsy, PD, PD and AD, AD, brain tumor, MG, CKD, and PD.